1. Scrip
  2. >>Focus On Asia
  3. >>South Korea

Collaborate Rather Than Compete: Korea’s Push Toward A Biopharma Powerhouse

Industry Begins To Take Collective Moves

 
• By Jung Won Shin

Korean biopharma companies and the government are making diverse efforts to collaborate and seek growth to overcome limited resources and capital, as well as a tough investment environment.

Collaboration
Will Korea Go Down The Global Big Pharma Road? • Source: Shutterstock

Collaborate. Collaborate. Collaborate. This seems to be the message the South Korean biopharma industry intends to emphasize this year, while the government rushes to unveil measures to support the sector and launches regulatory innovation initiatives.

Korean pharmas are increasingly feeling the need to join hands and work with one another as out-licensing deals, particularly large-scale, cross-border ones, which have been a key part of

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from South Korea

More from Focus On Asia